XTalks
DECEMBER 28, 2023
It stands out as the sole reported therapy under clinical evaluation for treating alloimmunized pregnant individuals at significant risk of severe HDFN. “The ability to detect fetal antigens as early as ten weeks is only made possible due to our expertise in fetal DNA quantification.
VirTrial
OCTOBER 14, 2020
The training and certification initiative aims to provide sustainable study and patient opportunities for investigator sites, while demonstrating telemedicine technology competencies in the eyes of international regulators. “VirTrial was created with sites in mind from the start,” says Kim Kundert, Executive Vice President.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 18, 2020
(NASDAQ:CDXC) today highlighted a new study published in The European Molecular Biology Organization Journal looking at the effect of nicotinamide riboside (NR) on maintaining telomeres, the protective regions at the end of DNA strands. Telomeres are “caps” at the end of chromosomes that protect DNA from getting worn away as cells replicate.
Cloudbyz
NOVEMBER 3, 2021
Biosamples and biomarkers are the core basis for much of the work done in the clinical research industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. For a rapidly growing subfield of clinical research such as HBSM, the long-term future can be very difficult to predict.
Drug Discovery World
AUGUST 3, 2023
Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance. My mission is to see cannabis regulators understand basic science and to consult experienced scientists to refine regulations.
Drug Discovery World
NOVEMBER 8, 2023
Harnessing AI, researchers have significantly expedited the drug discovery process, achieving what traditionally takes years in just 30 days. This method not only promises more efficient drug development but could also revolutionise clinical research and accelerate trials.
XTalks
NOVEMBER 7, 2022
Liquid biopsy tests in oncology involve isolating entities such as circulating tumor cells (CTC), circulating tumor DNA (ctDNA) and tumor-derived exosomes. The cfDNA that originates from tumors is called circulating tumor DNA (ctDNA). These tumor-derived entities are used to derive genomic and proteomic data.
Expert insights. Personalized for you.
97 
Let's personalize your content